Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00397917 · ClinicalTrials.gov registry record · Phase 3
Oral Cleft Prevention Program
A Phase 3 study, sponsored by University of Iowa.
- Completed
- Registry status
- Phase 3
- Development phase
- 4,000
- Enrollment target
NCT00397917 is a Phase 3 study that has completed, run by University of Iowa. The registered enrollment target is 4,000 participants.
The verdict
NCT00397917, a Phase 3 study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 4,000 participants
- Enrollment target
Study Summary
The purpose of this study is to asses if taking 4 mg of folic acid per day at preconception and during the first three months of pregnancy decreases the risk of having a child with cleft lip and palate compared to 0.4 mg folic acid for women who have an oral cleft or have had previously child with an oral cleft.
Interventions
- DRUG Folic acid: 4 mg versus 0.4 mg per day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2006-11 |
| Est. Completion | 2013-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00397917
The ClinicalTrials.gov registry entry for NCT00397917 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Folic acid: 4 mg versus 0.4 mg per day is the first listed.
NCT00397917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00397917 about?
NCT00397917 is a clinical study titled "Oral Cleft Prevention Program". The purpose of this study is to asses if taking 4 mg of folic acid per day at preconception and during the first three months of pregnancy decreases the risk of having a child with cleft lip and palate compared to 0.4 mg folic acid for women who have an oral cleft or have had previously child with a...
What is the current status of trial NCT00397917?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,000 participants. The study started on 2006-11. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00397917?
The interventions under investigation include: Folic acid: 4 mg versus 0.4 mg per day (DRUG).
Who is sponsoring clinical trial NCT00397917?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.